The UCSC Genome Sequencing Center is now available to accept samples from investigators at other academic institutions as well as regional biotechnology companies. The UCSC Genome Sequencing Center ...
ctDNA as a biomarker in phase II study of tepotinib in advanced solid cancers with MET exon 14 skipping mutation or amplification (KCSG AL19-17). Characterization of molecular response and progression ...
Our Lab established next-generation sequencing (NGS) in 2017 to detect molecular alterations in solid tumors for diagnosis and to identify therapeutic targets. Our Lab is referral for various regional ...
We validated a clinical bait-capture WTS assay using 78 solid tumor samples across diverse tissue types, including 59 with known fusions or oncogenic splice variants. Sensitivity was assessed against ...
Next-generation sequencing (NGS) has arrived. “The expansion of users and applications shows no signs of abating,” notes Michael Rhodes, Ph.D., senior manager, SOLiD Sequencing at Applied Biosystems, ...